注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Immuron Ltd是一家商業和臨床階段的生物製藥公司,專注於多克隆抗體的開發和商業化,以滿足未滿足的醫療需求。該公司通過兩個部門運營:研發(R&D)部門和超免疫產品部門。研發部門專注於在澳大利亞、以色列和美國進行的研發項目。超免疫產品部門在澳大利亞、美國和加拿大從事Travelan和Protectyn產品活動。該公司的旗艦產品包括Travelan和Protectyn。Travelan是一種獲得許可的天然保健產品,用於降低旅行者腹瀉的風險。Travelan是一種非處方免疫補充劑,可用於降低腹瀉風險並減輕輕微胃腸道疾病的症狀。Protectyn產品有助於促進消化和健康的胃腸系統健康;支持和維持健康的肝功能,增強免疫防禦。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Daniel Pollock | 63 | 2012 | Independent Non-Executive Director |
Glenn S. Tillotson | - | - | Member of Advisory Board |
Miriam Vos | - | - | Member of Advisory Board |
Arun J. Sanyal | - | - | Member of Advisory Board |
Dena Lyras | - | - | Member of Advisory Board |
Stephen Anastasiou | 66 | 2013 | Independent Non-Executive Director |
Teena Chopra | - | - | Member of Advisory Board |
Ravi Savarirayan | 56 | 2017 | Independent Non-Executive Director |
Gerhard Rogler | - | - | Member of Advisory Board |
Stephen A. Harrison | - | - | Member of Advisory Board |
Paul Feuerstadt | - | - | Member of Advisory Board |
Sahil Khanna | - | - | Member of Advisory Board |
Manal Abdelmalek | - | - | Member of Advisory Board |
Roger Aston | 67 | 2012 | Independent Non-Executive Director |
Paul Brennan | 62 | 2022 | Independent Non-Executive Chairman |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核